-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein
Original Research
(3282) Views (616) Full article downloads
Authors: Miguel Arturo Salazar, Vázquez, Beatriz Yadira Salazar, Vázquez, M Intaglietta, Pedro Cabrales
Published Date September 2008
Volume 2009:5 Pages 65 - 72
DOI: http://dx.doi.org/10.2147/VHRM.S3892
Miguel Arturo Salazar Vázquez1, Beatriz Yadira Salazar Vázquez2,3, M Intaglietta3, Pedro Cabrales4
1Facultad de Ciencias Químicas Gómez Palacio, Universidad Juárez del Estado de Durango, Dgo., México; 2Faculty of Medicine, Universidad Juárez del Estado de Durango, Victoria de Durango Dgo., México; 3Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; 4La Jolla Bioengineering Institute, La Jolla, CA, USA
Abstract: Nonobese children age 10.4 ± 1.1 years diagnosed with dyslipidemia (n = 51) were compared to normal children age 10.8 ± 1.1 years (n = 38). Affected individuals had increased total cholesterol: 223 ± 23 vs 152 ± 17 mg/dl, p < 0.001; and decreased high-density lipoprotein-cholesterol: 41.9 ± 4.1 vs 57.6 ± 5.7 mg/dl, p < 0.001 and triglycerides: 90.8 ± 40.5 vs 65.7 ± 25.0 mg/dl, p < 0.002. Fasting glucose was also significantly elevated (p < 0.02). All other parameters, including blood pressure, were not statistically different between groups. The concentration of C-reactive protein was not statistically different between groups. Analysis of medical records showed that this anomaly may be related to this group (as well as the control group) performing regular, daily exercise. This activity was quantified via a self administered questionnaire, and found to be statistically identical in controls and dyslipidemic individuals. Exercise is associated with the release of antiinflammatory cytokines, therefore our results support the contention that it is a significant factor in promoting health conditions from an early stage in life.
Keywords: dyslipidemia, C-reactive protein, children, exercise, inflammation, diabetes, obesity, metabolic syndrome, hispanics
Other articles by Dr Pedro Cabrales
Hematocrit and mean arterial blood pressure in pre- and postmenopause women
Readers of this article also read:
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Everolimus-eluting stents: update on current clinical studies
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




